INMB - Inmune Bio, Inc.
IEX Last Trade
4.72
0.020 0.424%
Share volume: 2,585
Last Updated: Thu 26 Dec 2024 08:30:11 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$4.70
0.02
0.43%
Summary score
20%
Profitability
25%
Dept financing
8%
Liquidity
52%
Performance
11%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2020 - 30-Jun-2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-14.88%
Return on assets
-10.79%
Return on sales
-33051.7%
Return on invested capital
91.66%
Total debt ratio
22.22%
Debt ratio change over timeo
-1.23%
Current Ratio
12.22%
Quick Ratio
12.22%
Cash Position Ratio
10.94%
Short-term ratios 30-Jun-2023 - 30-Jun-2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-26.9%
Return on assets
-17.66%
Return on sales
-42816.81%
Return on invested capital
568.35%
Total debt ratio
33.43%
Debt ratio change over timeo
-1.02%
Current Ratio
2.35%
Quick Ratio
2.35%
Cash Position Ratio
2.1%
Last quarter ratios 30-Jun-2024
The data are presented for the financials results of the last quarter.
Return on equity
-26.86%
Return on assets
-18.81%
Return on sales
0%
Return on invested capital
-511.06%
Total debt ratio
30.83%
Debt ratio change over time
-1.06%
Current Ratio
2.36%
Quick Ratio
2.36%
Cash Position Ratio
2.06%
Performance ratios (change over 4 years) 30-Jun-2020 - 30-Jun-2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-83.68%
Return on assets
-86.58%
Return on sales
42036%
Return on invested capital
35.09%
Total debt ratio
-123.43%
Debt ratio change over time
-1.23%
Current Ratio
-24.82%
Quick Ratio
-24.82%
Cash Position Ratio
-22.51%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | INMB | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -14.88% | 15.05% | 35.64% | 7.13% |
| Return on assets | -10.79% | 2.88% | 3.13% | 5.53% |
| Return on sales | -33051.7% | 29.62% | 32.25% | 40.49% |
| Return on invested capital | 91.66% | 2.57% | 5.37% | 18.48% |
| Profitability | 25% | 43% | 61% | 60% |
| Total debt ratio | 22.22% | 90.48% | 91% | 25.78% |
| Debt ratio change over time | -1.23% | 326.95% | -8.44% | 1.18% |
| Dept financing | 6% | 50% | 25% | 7% |
| Current Ratio | 2.35% | 0.92% | 1.98% | 5.39% |
| Quick Ratio | 2.35% | 0.81% | 1.56% | 4.63% |
| Cash Position Ratio | 2.1% | 0.39% | 1.05% | 2.91% |
| Liquididy | 75% | 4% | 9% | 23% |
| Short-term ratios | INMB | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -26.9% | 13.14% | 10.88% | 4.07% |
| Return on assets | -17.66% | 2.1% | 1.54% | 3.03% |
| Return on sales | -42816.81% | 21.74% | 18.43% | 30.26% |
| Return on invested capital | 568.35% | 1.95% | 2.74% | 9.55% |
| Profitability | 25% | 60% | 49% | 58% |
| Total debt ratio | 33.43% | 92.68% | 93.24% | 21.84% |
| Debt ratio change over time | -1.02% | 51.04% | -101.54% | 1.43% |
| Dept financing | 9% | 50% | 25% | 7% |
| Current Ratio | 2.35% | 0.92% | 1.98% | 5.39% |
| Quick Ratio | 2.35% | 0.81% | 1.56% | 4.63% |
| Cash Position Ratio | 2.1% | 0.39% | 1.05% | 2.91% |
| Liquididy | 42% | 12% | 27% | 75% |